Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?
Publication
, Journal Article
Foster, MH
Published in: Kidney Int
March 2004
Duke Scholars
Published In
Kidney Int
DOI
ISSN
0085-2538
Publication Date
March 2004
Volume
65
Issue
3
Start / End Page
1105 / 1106
Location
United States
Related Subject Headings
- Urology & Nephrology
- Oxidative Stress
- Humans
- HIV Protease Inhibitors
- Antiretroviral Therapy, Highly Active
- Animals
- AIDS-Associated Nephropathy
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Foster, M. H. (2004). Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome? Kidney Int, 65(3), 1105–1106. https://doi.org/10.1111/j.1523-1755.2004.00527.x
Foster, Mary Helen. “Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?” Kidney Int 65, no. 3 (March 2004): 1105–6. https://doi.org/10.1111/j.1523-1755.2004.00527.x.
Foster MH. Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome? Kidney Int. 2004 Mar;65(3):1105–6.
Foster, Mary Helen. “Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?” Kidney Int, vol. 65, no. 3, Mar. 2004, pp. 1105–06. Pubmed, doi:10.1111/j.1523-1755.2004.00527.x.
Foster MH. Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome? Kidney Int. 2004 Mar;65(3):1105–1106.
Published In
Kidney Int
DOI
ISSN
0085-2538
Publication Date
March 2004
Volume
65
Issue
3
Start / End Page
1105 / 1106
Location
United States
Related Subject Headings
- Urology & Nephrology
- Oxidative Stress
- Humans
- HIV Protease Inhibitors
- Antiretroviral Therapy, Highly Active
- Animals
- AIDS-Associated Nephropathy
- 3202 Clinical sciences
- 1103 Clinical Sciences